Mersana Therapeutics Inc. Common Stock is a biopharmaceutical company focused on developing novel antibody-drug conjugates (ADCs) for the treatment of various types of cancer. With a strong pipeline and promising clinical data, Mersana has the potential to revolutionize cancer treatment.
